Hopefully an optimized trial targeting the patients that will benefit most will show meaningful results sooner.
Some groups had 150% increase in OS over five year period. It will still be a long trial, imo. But, targeting the right patients should show great results sooner as the trial progresses, which will keep the market interested.
Hopefully an optimized trial targeting the patients that will...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.010(2.94%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.5¢ | 34.0¢ | $569.3K | 1.637M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 199417 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 378267 | 41 |
View Market Depth
| Last trade - 13.05pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |